drugset / Trial / NCT02254811
FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff
RandomizedSingle-groupOpen-labelTreatment
Summary
Delivery of FMT by upper route, including gastroscopy, nasogastric/ nasojejunal tube, and lower route, including retention enema, sigmoidoscopy, or colonoscopy have all been utilized successfully. Endoscopic delivery requires significant health care utilization and associated cost. Therefore, it is extremely desirable if FMT can be infused by a non invasive modality, which would significantly reduce patient discomfort, procedure related risks and health care costs, while offering similar efficacy to colonoscopic delivery in the range of 90%.
Timeline
- Start
- 2014-09-18
- Primary completion
- 2016-12-12
- Completion
- 2017-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fecal Microbiota Transplant | Other / unclassified | — | Oral |